Bio Key International Inc. BKYI
Computer Software: Prepackaged Software · data as of November 13, 2026
Bio Key International Inc. (BKYI) is a technology company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $7M and net income of -$6M, a net margin of -89.8%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 16% a year, a 5-year average ROIC of -201%.
About Bio Key International
Bio Key International is listed in the US and classified in computer software: prepackaged software. Revenue went from $4M in 2014 to $6M in 2025, growth of about 3.6% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 52% over three years (dilution for shareholders). It spends 44% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $6M | $7M | $8M | $7M | $5M | $3M | $2M | $4M | $6M | $3M |
| Net income | -$6M | -$7M | -$4M | -$9M | -$12M | -$5M | -$10M | -$15M | -$7M | -$4M | -$4M |
| Free cash flow | -$4M | -$5M | -$3M | -$4M | -$6M | -$9M | -$5M | -$2M | -$2M | -$3M | -$4M |
| EPS (diluted) | $-3.56 | $-3.59 | $-6.96 | $-5.07 | $-9.09 | $-0.22 | $-0.69 | $-2.74 | $-1.95 | $-2.03 | $-2.37 |
| Net margin | -89.8% | -120.5% | -62.1% | -109.9% | -169.6% | -99.1% | -341.0% | -643.4% | -169.8% | -67.8% | -140.8% |
| ROIC | — | -104.6% | -102.6% | -608.1% | -166.6% | -24.6% | -19.5% | -158.9% | 0.0% | -24.6% | -21.5% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 1 analysts is $20.00, 843% above the current price; targets range from $20.00 to $20.00; the consensus rating is “none”; expected EPS is $-1.62 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Bio Key International pay a dividend?
Not currently.
Is Bio Key International a good stock to buy?
We do not give buy or sell advice. Bio Key International scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.